Effect of roxithromycin on airway responsiveness in children with bronchiectasis: A double-blind, placebo-controlled study

European Respiratory Journal

Volumn 10, Issue 5, 1997, Pages 994-999

  Koh, Y Y ^a,b   Lee, M H ^a   Sun, Y H ^a   Sung, K W ^a   Chae, J H ^a  

^a Seoul National University   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

airway responsiveness; bronchiectasis; maximal response; provocative concentration; roxithromycin

Indexed keywords

PLACEBO; ROXITHROMYCIN;

ADOLESCENT; ARTICLE; BRONCHIECTASIS; BRONCHUS REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0030998918     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10050994     Document Type: Article

References (35)

1. Stillwell PC. Bronchiectasis. In: Loughlin GM, Eigen H, eds. Respiratory Disease in Children. Diagnosis and Management. Baltimore, Williams and Wilkins, 1994; pp. 307-314.
2. Cole PJ. A new look at the pathogenesis and management of persistent bronchial sepsis: a "vicious circle" hypothesis and its logical therapeutic connotations. In: Davies RJ, ed. Strategies in the Management of Chronic Bronchial Sepsis. Oxford, Medicine Publishing Foundation, 1984; pp. 1-16.
3. Cole PJ. Inflammation: a two-edged sword, the model of bronchiectasis. Eur J Respir Dis 1986; 69 (Suppl. 147): 6-15.
4. Bahous J, Cartier A, Pineau L, et al. Pulmonary function tests and airway responsiveness to methacholine in chronic bronchiectasis of the adult. Bull Eur Physiopathol Respir 1984; 20: 375-380.
5. Pang J, Chan HS, Sung JY. Prevalence of asthma, atopy, and bronchial hyperreactivity in bronchiectasis: a controlled study. Thorax 1989; 44: 948-951.
6. Ip M, Lam WK, So SY, Liong E, Chan CY, Tse KM. Analysis of factors associated with bronchial hyperreactivity to methacholine in bronchiectasis. Lung 1991; 169: 43-51.
7. Ip M, Shum D, Lauder I, Lam WK, So SY. Effect of antibiotics on sputum inflammatory contents in acute exacerbations of bronchiectasis. Respir Med 1993; 87: 449-454.
8. Cole PJ, Roberts DE, Davies SF, Knight PK. A simple oral antimicrobial regimen effective in severe chronic bronchial suppuration associated with culturable Haemophilus influenzae. J Antimicrob Chemother 1983; 11: 109-113.
9. Hill SL, Morrison HM, Burnett D, Stockley RA. Short-term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses, orally or by inhalation. Thorax 1986; 41: 559-565.
10. Hill SL, Burnett D, Hewetson KA, Stockley RA. The response of patients with purulent bronchiectasis to antibiotics for four months. Q J Med 1988; 66: 163-173.
11. Kelly CA, Stenton C, Gould K, Hendrick DJ. The effect of high-dose amoxycillin on bronchial responsiveness and symptoms in patients with bronchiectasis. Am Rev Respir Dis 1987; 135: A269.
12. Miyatake H, Taki F, Taniguchi H, Suzuki R, Takagi K, Satake T. Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma. Chest 1991; 99: 670-673.
13. Shimizu T, Kato M, Mochizuki H, Tokuyama K, Morikawa A, Kuroume T. Roxithromycin reduces the degree of bronchial hyperresponsiveness in children with asthma. Chest 1994; 106: 458-461.
14. Labro MT, Benna JE, Babin-Chevaye C. Comparison of the in vitro effect of several macrolides on the oxidative burst of human neutrophils. J Antimicrob Chemother 1989; 24: 561-572.
15. Holgate ST, Beasley R, Twentyman OP. The pathogenesis and significance of bronchial hyperresponsiveness in airway disease. Clin Sci 1987; 73: 561-572.
16. Woolcock AJ, Salome CM, Van K. The shape of the dose-response curve to histamine in asthmatic and normal subjects. Am Rev Respir Dis 1984; 130: 71-75.
17. Sterk PJ, Bel EH. Bronchial hyperresponsiveness: the need for a distinction between hypersensitivity and excessive airway narrowing. Eur Respir J 1989; 2: 267-274.
18. Shapiro GG, Furukawa CT, Pierson WE, Bierman CW. Methacholine bronchial challenge in children. J Allergy Clin Immunol 1982; 69: 365-369.
19. Yoon KA, Lim HS, Koh YY, Kim H. Normal predicted values of pulmonary function tests in Korean school-aged children. J Korean Pediatr Assoc 1993; 36: 25-37.
20. Chai H, Farr RS, Froelich LA, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975; 56: 323-327.
21. Sterk PJ, Timmers MC, Dijkman JH. Maximal airway narrowing in humans in vivo: histamine compared with methacholine. Am Rev Respir Dis 1986; 134: 714-718.
22. Bazet MC, Blanc F, Chumdermpadetsuk S, et al. Roxithromycin in the treatment of paediatric infections. Br J Clin Pract 1988; 42 (Suppl. 55): 117-118.
23. Juniper EF, Frith PA, Dunnett C, Cockcroft DW, Hargreave FE. Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax 1978; 33: 705-710.
24. Koh YY, Lee MH, Yoon KA, Seoung GW. The effect of roxithromycin on the bronchial responsiveness in children with bronchiectasis. Pediatr Allergy Respir Dis (Korean) 1996; 6: 74-85.
25. Bel EH, Timmers MC, Zwinderman AH, Dijkman JH, Sterk PJ. The effect of inhaled corticosteroids on the maximal degree of airway narrowing to methacholine in asthmatic subjects. Am Rev Respir Dis 1991; 143: 109-113.
26. Kerrebijn KF, van Essen-Zandvliet EEM, Neijens HJ. Effect of long-term treatment with inhaled corticosteroids and β-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol 1987; 79: 653-659.
27. 4 and methacholine in normal subjects in vivo. Am Rev Respir Dis 1989; 139: 427-431.
28. Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977; 7: 235-243.
29. Murphy MB, Reen DJ, Fitzgerald MX. Atopy, immunological changes and respiratory function in bronchiectasis. Thorax 1984; 39: 179-184.
30. Boonsawat W, Salome CM, Woolcock AJ. Effect of allergen inhalation on the maximal response plateau of the dose-response curve to methacholine. Am Rev Respir Dis 1992; 146: 565-569.
31. Boushey HA, Holtzman MJ, Sheeler JR, Nadel JA. State of art: bronchial hyperreactivity. Am Rev Respir Dis 1980; 121: 389-408.
32. Anderson R. Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated Superoxide generation and auto-oxidation. J Infect Dis 1989; 159: 966-973.
33. Konno S, Asano K, Kurokawa M, Ikeda K, Okamoto K, Adachi M. Antiasthmatic activity of a macrolide antibiotic, roxithromycin: analysis of possible mechanisms in vitro and in vivo. Int Arch Allergy Immunol 1994; 105: 308-316.
34. Kamoi H, Kurihara N, Fujiwara H, Hirata K, Takeda T. The macrolide antibacterial roxithromycin reduces bronchial hyperresponsiveness and Superoxide anion production by polymorphonuclear leukocytes in patients with asthma. J Asthma 1995; 32: 191-197.
35. Elborn JS, Johnston B, Allen F, Clarke J, McGarry J, Varghese G. Inhaled steroids in patients with bronchiectasis. Respir Med 1992; 86: 121-124.